1 / 8

United States Biopsy Market will be USD 14 Billion by 2025

United States Biopsy Market will cross US$ 17 Billion by the year 2024. US Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver and Thyroid), Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, FUJIFILM Holdings Corporation, Medtronic plc., Hologic, Inc

renubresearch
Télécharger la présentation

United States Biopsy Market will be USD 14 Billion by 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. United States Biopsy Market United States Biopsy Market

  2. Report Description and Highlights Liquid biopsies offer a secure and reliable way to collect samples, to treat invasively and to diagnose more rapidly, resulting in increased demand for these tools. It is a rapid process that usually involves simply drawing blood, extracting nucleic acids from the blood plasma, and amplifying molecular targets to allow the identified biomarkers. Increasing awareness of minimally invasive procedures, favorable government initiatives and the presence of an immense cancer population base are key drivers of market growth. United States Biopsy Market is predicted to surpass USD 14 Billion by the end of the year 2025. Renub Research report titled “United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver ,Thyroid, Kidney, Colorectal and Skin) Cancer, Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, FUJIFILM Holdings Corporation, Medtronic plc., Hologic, Inc)” provides a complete analysis of the United States Biopsy Market and Volume. United States Biopsy Market

  3. United States Biopsy Market The major factors that fuel the United States liquid biopsy market are; increasing prevalence of different types of cancer, non-invasive techniques such as liquid biopsy tests are in more demand in United States, comfort of patient, detection of tumor in early stages, rising healthcare infrastructure, increasing per capita income and increasing awareness regarding liquid biopsy in United States. The key obstacles against United States growth in the market for liquid biopsy are the lack of reimbursements and constantly changing regulations for laboratory-developed tests leading to growing costs of new tests and delays in market availability, low specificity and sensitivity. Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=united-states-biopsy-testing-market-and-volume-analysis-to-2020-511-p.php United States Biopsy Market

  4. United States Biopsy Market Market Summary: By Segments: Different types of cancer are being examined in this biopsy market; Liver Cancer Biopsy, Thyroid Cancer Biopsy, Kidney Cancer Biopsy, Colorectal Cancer Biopsy, Skin Cancer Biopsy, Lung Cancer Biopsy, Prostate Cancer Biopsy and Breast Cancer Biopsy. This study provides a multi-factorial overview of why the rate of biopsy in the United States is growing by a different type of cancer biopsy test. By Companies: This report included all top key players analysis; Hologic, Inc, Medtronic plc, FUJIFILM Holdings Corporation, Olympus Corporation, Cardinal Health, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company and C. R. Bard, Inc. United States Biopsy Market

  5. Key Topics Covered in United States Biopsy Market Key Topics Covered : Introduction 2.    Research Methodology 3.    Executive Summary 4.    United States Biopsy Market & Volume 4.1    Market & Forecast4.2    Volume & Forecast 5.    United States Biopsy Share 5.1    Market Share & Forecast5.2    Volume Share & Forecast United States Biopsy Market

  6. Key Topics Covered in United States Biopsy Market 6.    Segment – United States Biopsy Market 6.1    Prostate Cancer Biopsy 6.2    Breast Cancer Biopsy6.3    Lung Cancer Biopsy 6.4    Liver Cancer Biopsy6.5    Thyroid Cancer Biopsy 6.6    Kidney Cancer Biopsy6.7    Colon & Rectum Cancer Biopsy 6.8    Melanoma Skin Cancer Biopsy 7.    Company Analysis 7.1    Becton, Dickinson & Company 7.2    B. Braun Melsungen AG (Germany)7.3    Cardinal Health, Inc. 7.4    Olympus Corporation (Japan)7.5    Boston Scientific Corporation (U.S.) 7.6    Medtronic Plc.7.7    Hologic, Inc. United States Biopsy Market

  7. Key Topics Covered in United States Biopsy Market 8.    Growth Factors 8.1    Inadequate Screening Tests for Particular Cancers8.2    Demand for Minimally-Invasive Biopsy Techniques8.3    Advancement in Biopsy Techniques 9.    Challenges 9.1    Reimbursement Issues9.2    Limitations Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=united-states-biopsy-testing-market-and-volume-analysis-to-2020-511-p.php United States Biopsy Market

  8. United States Biopsy Market • Browse Related Report : • Global biopsy device market • Global Liquid Biopsy Market • Contact Us • Tel: +1-678-302-0700 (US), • +91-120-421-9822 (INDIA) • Email: info@renub.com United States Biopsy Market

More Related